Quick Takeaways
- Ikarian Capital, LLC filed SCHEDULE 13G/A for Forte Biosciences, Inc. Common Stock, $0.001 par value (FBRX).
- Disclosed ownership: 5%.
- Date of event: 30 Jun 2025.
Ikarian Capital, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Forte Biosciences, Inc. Common Stock, $0.001 par value (FBRX)
- Filing Manager
- Ikarian Capital, LLC
- Reporting Manager
- Ikarian Capital, LLC
- Symbol
- FBRX
- Shares outstanding
- 12,378,096 shares
- Disclosed Ownership
- 617,667 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 16:20:41 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ikarian Capital, LLC disclosed 5% ownership in Forte Biosciences, Inc. Common Stock, $0.001 par value (FBRX) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 14 Aug 2025, 16:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 5% | 617,667 | 0 | 617,667 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager | |
| Neil Shahrestani | 5% | 617,667 | 0 | 617,667 | /s/ Neil Shahrestani | Neil Shahrestani |